These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15871779)

  • 1. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
    Cabrera C; Clotet B
    Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia.
    Sirvent JL; Socas MM; Calzadilla CH; Lirola AM; Valls MR
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):111-3. PubMed ID: 16123693
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of protease and reverse transcriptase genes of HIV for antiretroviral drug resistance in Jamaican adults.
    Hamilton CL; Eyzaguirre LM; Amarakoon II; Figueroa P; Duncan J; Carr JK; Roye ME
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):923-7. PubMed ID: 22049946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral drug resistance among antiretroviral-naive individuals with HIV infection of unknown duration in Thailand.
    Apisarnthanarak A; Mundy LM
    Clin Infect Dis; 2008 May; 46(10):1630-1. PubMed ID: 18419506
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.
    Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M
    Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues.
    Antonelli G
    Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    Balduin M; Sierra S; Däumer MP; Rockstroh JK; Oette M; Fätkenheuer G; Kupfer B; Beerenwinkel N; Hoffmann D; Selbig J; Pfister HJ; Kaiser R
    J Clin Virol; 2005 Dec; 34(4):277-87. PubMed ID: 16191482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance testing.
    Cane P
    Methods Mol Biol; 2011; 665():123-32. PubMed ID: 21116799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
    Klibanov OM; Dolder CR; Assefa F; Ekwonu TJ
    AIDS Patient Care STDS; 2013 Apr; 27(4):205-7. PubMed ID: 23514132
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
    van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
    AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transmission of antiretroviral drug resistant strains in patients diagnosed with human immunodeficiency virus infection in Gran Canaria in the period 2009-2012].
    Chamizo-López FJ; Gilarranz-Luengo R; Hernández-Febles M; Pena-López MJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):695-6. PubMed ID: 24666476
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of antiretroviral drug resistance.
    Wainberg MA; Zaharatos GJ; Brenner BG
    N Engl J Med; 2011 Aug; 365(7):637-46. PubMed ID: 21848464
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to antiretroviral therapy.
    Deshpande A
    J Assoc Physicians India; 2012 Dec; 60():9. PubMed ID: 23781663
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings.
    Bertagnolio S; Perno CF; Vella S; Pillay D
    J Infect Dis; 2013 Jun; 207 Suppl 2():S45-8. PubMed ID: 23687288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resistance to protease inhibitors: the burden of mutations].
    Marcelin AG
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S198-205. PubMed ID: 17075997
    [No Abstract]   [Full Text] [Related]  

  • 18. INFECTIOUS DISEASE. Researchers claim to find HIV sanctuaries.
    Cohen J
    Science; 2016 Jan; 351(6272):434. PubMed ID: 26823407
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 20. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.